<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font22">and </span>
   <span class="font14">with </span>
   <span class="font13">viral </span>
   <span class="font13">The </span>
   <span class="font13">are </span>
   <span class="font13">for </span>
   <span class="font12">COVID- </span>
   <span class="font12">SARS-CoV- </span>
   <span class="font12">clinical </span>
   <span class="font12">[]. </span>
   <span class="font12">host </span>
   <span class="font12">patients </span>
   <span class="font11">that </span>
   <span class="font11">which </span>
   <span class="font11">protein </span>
   <span class="font11">RNA </span>
   <span class="font11">from </span>
   <span class="font11">have </span>
   <span class="font11">cell </span>
   <span class="font11">into </span>
   <span class="font11">ACE </span>
   <span class="font11">vaccine </span>
   <span class="font11">virus </span>
   <span class="font11">{background </span>
   <span class="font11">been </span>
   <span class="font11">cells </span>
   <span class="font11">its </span>
   <span class="font10">proteins </span>
   <span class="font10">vaccines </span>
   <span class="font10">including </span>
   <span class="font10">immune </span>
   <span class="font10">treatment </span>
   <span class="font10">coronavirus </span>
   <span class="font10">entry </span>
   <span class="font10">COVID-. </span>
   <span class="font10">margin </span>
   <span class="font10">such </span>
   <span class="font10">also </span>
   <span class="font10">efficacy </span>
   <span class="font10">{border-style </span>
   <span class="font10">against </span>
   <span class="font10">antibodies </span>
   <span class="font10">has </span>
   <span class="font10">not </span>
   <span class="font10">px;} </span>
   <span class="font10">severe </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">data </span>
   <span class="font10">expression </span>
   <span class="font10">other </span>
   <span class="font10">respiratory </span>
   <span class="font10">specific </span>
   <span class="font10">human </span>
   <span class="font10">effects </span>
   <span class="font10">neutralizing </span>
   <span class="font10">replication </span>
   <span class="font10">TMPRSS </span>
   <span class="font10">number </span>
   <span class="font10">phase </span>
   <span class="font10">target </span>
   <span class="font10">through </span>
   <span class="font10">about </span>
   <span class="font10">but </span>
   <span class="font10">disease </span>
   <span class="font10">gene </span>
   <span class="font10">mRNA </span>
   <span class="font10">might </span>
   <span class="font10">mortality </span>
   <span class="font10">new </span>
   <span class="font10">randomized </span>
   <span class="font10">studies </span>
   <span class="font10">because </span>
   <span class="font10">effective </span>
   <span class="font10">genome </span>
   <span class="font10">hospitalized </span>
   <span class="font10">infection </span>
   <span class="font10">involved </span>
   <span class="font10">response </span>
   <span class="font10">was </span>
   <span class="font10">Likewise, </span>
   <span class="font10">outcomes </span>
   <span class="font10">structural </span>
   <span class="font10">syndrome </span>
   <span class="font10">upon </span>
   <span class="font10">basic </span>
   <span class="font10">levels </span>
   <span class="font10">several </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">[,]. </span>
   <span class="font10">antigen </span>
   <span class="font10">approach </span>
   <span class="font10">associated </span>
   <span class="font10">being </span>
   <span class="font10">cardiac </span>
   <span class="font10">cardiovascular </span>
   <span class="font10">cells, </span>
   <span class="font10">could </span>
   <span class="font10">develop </span>
   <span class="font10">discoveries </span>
   <span class="font10">host-immune </span>
   <span class="font10">large </span>
   <span class="font10">more </span>
   <span class="font10">multiple </span>
   <span class="font10">potential </span>
   <span class="font10">prevent </span>
   <span class="font10">protease </span>
   <span class="font10">relatively </span>
   <span class="font10">tested </span>
   <span class="font10">use </span>
   <span class="font10">various </span>
   <span class="font10">(reviewed </span>
   <span class="font10">However, </span>
   <span class="font10">Res </span>
   <span class="font10">acute </span>
   <span class="font10">among </span>
   <span class="font10">beneficial </span>
   <span class="font10">cellular </span>
   <span class="font10">cleavage </span>
   <span class="font10">development </span>
   <span class="font10">essential </span>
   <span class="font10">immunogenicity </span>
   <span class="font10">inactivated </span>
   <span class="font10">involvement </span>
   <span class="font10">membrane </span>
   <span class="font10">protein, </span>
   <span class="font10">px; </span>
   <span class="font10">recombinant </span>
   <span class="font10">science </span>
   <span class="font10">synthesis </span>
   <span class="font10">there </span>
   <span class="font10">this </span>
   <span class="font10">those </span>
   <span class="font10">trials </span>
   <span class="font10">within </span>
   <span class="font10">{font-family </span>
   <span class="font10">COVID-: </span>
   <span class="font10">[]). </span>
   <span class="font10">after </span>
   <span class="font10">care </span>
   <span class="font10">developed </span>
   <span class="font10">during </span>
   <span class="font10">epithelial </span>
   <span class="font10">expressed </span>
   <span class="font10">factors </span>
   <span class="font10">font-size </span>
   <span class="font10">immunity </span>
   <span class="font10">individuals </span>
   <span class="font10">infected </span>
   <span class="font10">largely </span>
   <span class="font10">less </span>
   <span class="font10">molecular </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">proteins, </span>
   <span class="font10">proteolytic </span>
   <span class="font10">rapid </span>
   <span class="font10">receptor </span>
   <span class="font10">receptors </span>
   <span class="font10">show </span>
   <span class="font10">shown </span>
   <span class="font10">small </span>
   <span class="font10">system </span>
   <span class="font10">targets </span>
   <span class="font10">than </span>
   <span class="font10">their </span>
   <span class="font10">therapies </span>
   <span class="font10">used </span>
   <span class="font10">who </span>
   <span class="font10">Engl </span>
   <span class="font10">Given </span>
   <span class="font10">Phase </span>
   <span class="font10">These </span>
   <span class="font10">This </span>
   <span class="font10">advances </span>
   <span class="font10">attenuated </span>
   <span class="font10">binding </span>
   <span class="font10">caused </span>
   <span class="font10">comprised </span>
   <span class="font10">convalescent </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">days </span>
   <span class="font10">developing </span>
   <span class="font10">double; </span>
   <span class="font10">elderly </span>
   <span class="font10">evidence </span>
   <span class="font10">function </span>
   <span class="font10">fusion </span>
   <span class="font10">high </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">increased </span>
   <span class="font10">inhibitors </span>
   <span class="font10">low </span>
   <span class="font10">only </span>
   <span class="font10">part </span>
   <span class="font10">plasma </span>
   <span class="font10">proteases </span>
   <span class="font10">reduce </span>
   <span class="font10">release </span>
   <span class="font10">structure </span>
   <span class="font10">study </span>
   <span class="font10">therapy </span>
   <span class="font10">these </span>
   <span class="font10">two </span>
   <span class="font10">type </span>
   <span class="font10">using </span>
   <span class="font10">well </span>
   <span class="font10">were </span>
   <span class="font10">(Fig.Ã‚ </span>
   <span class="font10">ACE, </span>
   <span class="font10">COVID-, </span>
   <span class="font10">DNA </span>
   <span class="font10">Elsevier </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">Several </span>
   <span class="font10">There </span>
   <span class="font10">airway </span>
   <span class="font10">amino </span>
   <span class="font10">analogues </span>
   <span class="font10">angiotensin </span>
   <span class="font10">antibody </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">case </span>
   <span class="font10">codes </span>
   <span class="font10">cytokine </span>
   <span class="font10">cytokines </span>
   <span class="font10">discussed </span>
   <span class="font10">drug </span>
   <span class="font10">drugs </span>
   <span class="font10">due </span>
   <span class="font10">effectively </span>
   <span class="font10">enabled </span>
   <span class="font10">endocytosis </span>
   <span class="font10">entry, </span>
   <span class="font10">first </span>
   <span class="font10">functions </span>
   <span class="font10">fundamental </span>
   <span class="font10">generation </span>
   <span class="font10">however, </span>
   <span class="font10">important </span>
   <span class="font10">injection </span>
   <span class="font10">known </span>
   <span class="font10">latter </span>
   <span class="font10">loss </span>
   <span class="font10">major </span>
   <span class="font10">most </span>
   <span class="font10">nafamostat </span>
   <span class="font10">often </span>
   <span class="font10">patients, </span>
   <span class="font10">production </span>
   <span class="font10">progress </span>
   <span class="font10">requiring </span>
   <span class="font10">resource </span>
   <span class="font10">response, </span>
   <span class="font10">response. </span>
   <span class="font10">role </span>
   <span class="font10">scientific </span>
   <span class="font10">serine </span>
   <span class="font10">solid; </span>
   <span class="font10">spike </span>
   <span class="font10">studies, </span>
   <span class="font10">susceptibility </span>
   <span class="font10">targeted </span>
   <span class="font10">test </span>
   <span class="font10">trial </span>
   <span class="font10">typically </span>
   <span class="font10">vaccination </span>
   <span class="font10">vaccines, </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">-day </span>
   <span class="font10">CI: </span>
   <span class="font10">Covid- </span>
   <span class="font10">IL, </span>
   <span class="font10">Med </span>
   <span class="font10">Nevertheless, </span>
   <span class="font10">Preliminary </span>
   <span class="font10">RBD </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">Sci </span>
   <span class="font10">Table </span>
   <span class="font10">Usual </span>
   <span class="font10">Vaccine </span>
   <span class="font10">Viral </span>
   <span class="font10">all </span>
   <span class="font10">along </span>
   <span class="font10">antigen, </span>
   <span class="font10">antigen. </span>
   <span class="font10">approved </span>
   <span class="font10">available </span>
   <span class="font10">basis </span>
   <span class="font10">bat </span>
   <span class="font10">between </span>
   <span class="font10">bold </span>
   <span class="font10">candidate </span>
   <span class="font10">candidates </span>
   <span class="font10">care: </span>
   <span class="font10">centre </span>
   <span class="font10">changes </span>
   <span class="font10">common </span>
   <span class="font10">components </span>
   <span class="font10">confer </span>
   <span class="font10">courier; </span>
   <span class="font10">currently </span>
   <span class="font10">cytokines, </span>
   <span class="font10">differences </span>
   <span class="font10">diseases </span>
   <span class="font10">domain </span>
   <span class="font10">dozen </span>
   <span class="font10">early </span>
   <span class="font10">effectiveness </span>
   <span class="font10">em; </span>
   <span class="font10">enables </span>
   <span class="font10">existing </span>
   <span class="font10">expected </span>
   <span class="font10">global </span>
   <span class="font10">humoral </span>
   <span class="font10">impact </span>
   <span class="font10">induce </span>
   <span class="font10">interventions </span>
   <span class="font10">knowledge </span>
   <span class="font10">large-scale </span>
   <span class="font10">leads </span>
   <span class="font10">likely </span>
   <span class="font10">load </span>
   <span class="font10">mRNA-based </span>
   <span class="font10">mesylate </span>
   <span class="font10">moderate </span>
   <span class="font10">newly </span>
   <span class="font10">nucleoside </span>
   <span class="font10">observational </span>
   <span class="font10">opposed </span>
   <span class="font10">outcomes, </span>
   <span class="font10">over </span>
   <span class="font10">peptide </span>
   <span class="font10">polypeptides </span>
   <span class="font10">possible </span>
   <span class="font10">preliminary </span>
   <span class="font10">prevention </span>
   <span class="font10">produce </span>
   <span class="font10">proinflammatory </span>
   <span class="font10">pt;} </span>
   <span class="font10">responses </span>
   <span class="font10">review </span>
   <span class="font10">risk </span>
   <span class="font10">robust </span>
   <span class="font10">safety </span>
   <span class="font10">secondary </span>
   <span class="font10">sequencing </span>
   <span class="font10">severity </span>
   <span class="font10">stability </span>
   <span class="font10">successful </span>
   <span class="font10">suggest </span>
   <span class="font10">support </span>
   <span class="font10">testing </span>
   <span class="font10">therapeutic </span>
   <span class="font10">thrombotic </span>
   <span class="font10">translational </span>
   <span class="font10">trials. </span>
   <span class="font10">usual </span>
   <span class="font10">vaccine, </span>
   <span class="font10">variant </span>
   <span class="font10">via </span>
   <span class="font10">virion </span>
   <span class="font10">virions </span>
   <span class="font10">virus, </span>
   <span class="font10">virus. </span>
   <span class="font10">viruses </span>
   <span class="font10">vitro </span>
  </p>
 </body>
</html>
